NU6102 is a selective and potent ATP-competitive CDK2 inhibitor with antitumor activity against CDK1/cyclinB, CDK2/cyclinA3, CDK1/CDK2, CDK4, DYRK1A , PDK1, and ROCKII, and it can be used to study rectal cancer.
Molecular Weight:
402.47
Purity:
99.58%
CAS Number:
[444722-95-6]
Formula:
C18H22N6O3S
Target:
CDK
T28218
* VAT and and shipping costs not included. Errors and price changes excepted